Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Melero

Showing results (161-170 of 176) with videos related to

Pageof 18
Sort By:
The Journal of General Virology|February 18, 2014
Characterization of an enhanced antigenic change in the pandemic 2009 H1N1 influenza virus haemagglutininBlanca García-Barreno, Teresa Delgado, Sonia Benito, et al.
Nature Communications|November 30, 2017
Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion stateIebe Rossey, Morgan S A Gilman, Stephanie C Kabeche, et al.
Plos One|June 25, 2015
Recombinant Soluble Respiratory Syncytial Virus F Protein That Lacks Heptad Repeat B, Contains a GCN4 Trimerization Motif and Is Not Cleaved Displays Prefusion-Like CharacteristicsIvy Widjaja, Alan Rigter, Shamir Jacobino, et al.
Virus Research|November 4, 2004
Respiratory syncytial virus and other pneumoviruses: a review of the international symposium--RSV 2003Alexander C Schmidt, Teresa R Johnson, Peter J M Openshaw, et al.
Science Immunology|January 24, 2017
Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donorsMorgan S A Gilman, Carlos A Castellanos, Man Chen, et al.
Nature Communications|February 15, 2017
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion stateIebe Rossey, Morgan S A Gilman, Stephanie C Kabeche, et al.
Virology Journal|April 19, 2015
Clinical response to pandemic H1N1 influenza virus from a fatal and mild case in ferretsPamela Martínez-Orellana, Jaume Martorell, Beatriz Vidaña, et al.
The Journal of General Virology|September 18, 2007
Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approachesSheng-Jiun Wu, Albert Schmidt, Eric J Beil, et al.
Nature Medicine|December 17, 2008
Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus diseaseMaria Florencia Delgado, Silvina Coviello, A Clara Monsalvo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2005
The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxinFernando P Polack, Pablo M Irusta, Scott J Hoffman, et al.
Pageof 18

Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
The Journal of General Virology|February 18, 2014
Characterization of an enhanced antigenic change in the pandemic 2009 H1N1 influenza virus haemagglutininBlanca García-Barreno, Teresa Delgado, Sonia Benito, et al.
Nature Communications|November 30, 2017
Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion stateIebe Rossey, Morgan S A Gilman, Stephanie C Kabeche, et al.
Plos One|June 25, 2015
Recombinant Soluble Respiratory Syncytial Virus F Protein That Lacks Heptad Repeat B, Contains a GCN4 Trimerization Motif and Is Not Cleaved Displays Prefusion-Like CharacteristicsIvy Widjaja, Alan Rigter, Shamir Jacobino, et al.
Virus Research|November 4, 2004
Respiratory syncytial virus and other pneumoviruses: a review of the international symposium--RSV 2003Alexander C Schmidt, Teresa R Johnson, Peter J M Openshaw, et al.
Science Immunology|January 24, 2017
Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donorsMorgan S A Gilman, Carlos A Castellanos, Man Chen, et al.
Nature Communications|February 15, 2017
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion stateIebe Rossey, Morgan S A Gilman, Stephanie C Kabeche, et al.
Virology Journal|April 19, 2015
Clinical response to pandemic H1N1 influenza virus from a fatal and mild case in ferretsPamela Martínez-Orellana, Jaume Martorell, Beatriz Vidaña, et al.
The Journal of General Virology|September 18, 2007
Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approachesSheng-Jiun Wu, Albert Schmidt, Eric J Beil, et al.
Nature Medicine|December 17, 2008
Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus diseaseMaria Florencia Delgado, Silvina Coviello, A Clara Monsalvo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2005
The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxinFernando P Polack, Pablo M Irusta, Scott J Hoffman, et al.
Pageof 18